| 000 | 01526 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250513185028.0 | ||
| 264 | 0 | _c19990716 | |
| 008 | 199907s 0 0 eng d | ||
| 022 | _a0039-2499 | ||
| 024 | 7 |
_a10.1161/01.str.30.7.1409 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aThomas, J E | |
| 245 | 0 | 0 |
_aSafety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. _h[electronic resource] |
| 260 |
_bStroke _cJul 1999 |
||
| 300 |
_a1409-16 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aCerebral Angiography |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aIntracranial Aneurysm _xcomplications |
| 650 | 0 | 4 |
_aIschemic Attack, Transient _xdiagnostic imaging |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNitroprusside _xadministration & dosage |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 |
_aSubarachnoid Hemorrhage _xcomplications |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aVasodilator Agents _xadministration & dosage |
| 650 | 0 | 4 | _aVentriculostomy |
| 700 | 1 | _aRosenwasser, R H | |
| 700 | 1 | _aArmonda, R A | |
| 700 | 1 | _aHarrop, J | |
| 700 | 1 | _aMitchell, W | |
| 700 | 1 | _aGalaria, I | |
| 773 | 0 |
_tStroke _gvol. 30 _gno. 7 _gp. 1409-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/01.str.30.7.1409 _zAvailable from publisher's website |
| 999 |
_c10348650 _d10348650 |
||